Serum transforming growth factor-β1 levels and pancreatic cancer risk: a nested case–control study (Japan)
✍ Scribed by Yingsong Lin; Shogo Kikuchi; Akiko Tamakoshi; Yuki Obata; Kiyoko Yagyu; Yutaka Inaba; Michiko Kurosawa; Takashi Kawamura; Yutaka Motohashi; Teruo Ishibashi; for the JACC Study Group
- Publisher
- Springer Netherlands
- Year
- 2006
- Tongue
- English
- Weight
- 129 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Smoking is the only generally accepted risk factor for pancreatic cancer. Reproductive history has in recent studies been associated with pancreatic cancer, but with contradictory results. In order to evaluate a possible association between age at first birth and the number of births and pancreatic
## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a case–con
## Abstract Previous studies indicate that calcium and its regulating hormones, __i.e__., parathyroid hormone (PTH) and vitamin D, might affect breast cancer risk. Evidence also suggests that this relationship could be influenced by menopausal status and BMI. We examined breast cancer risk related